文献速递乳腺MR

钆特酸MR乳腺摄影在1537例患者中的诊断效能与安全性

Diagnostic efficacy and safety of gadoteric acid MR mammography in 1537 patients.
PubMed 文献 · Eur J Radiol · 2016-10-14

这项在德国15个中心开展的多中心上市后监测研究纳入1537例接受静脉钆特酸增强高分辨率MR乳腺摄影的患者,99.2%的患者确立了诊断,91.6%的图像质量评为优秀或良好;以组织病理学为参考标准,钆特酸增强MR乳腺摄影对浸润性导管癌的诊断符合率为93.5%;药物不良反应发生率为0.3%(5/1537),其中1例分类为严重,所有出现不良反应的患者检查后均完全恢复。

要点

  • 99.2%的患者可确立诊断,91.6%的图像质量评为优秀或良好。
  • 以组织病理学为参考标准,浸润性导管癌的诊断符合率为93.5%。
  • 药物不良反应发生率0.3%(5/1537),严重1例,全部完全恢复。

核心结论

  • 这项非干预性监测研究显示,静脉钆特酸是用于MR乳腺摄影的安全有效的对比剂。

研究设计与样本

  • 多中心上市后监测研究(非干预性监测研究),在德国15个中心纳入1537例接受静脉钆特酸增强高分辨率MR乳腺摄影的患者,放射科医师采用标准化问卷报告患者人口学与病史、MR检查特征以及诊断和安全性结果,并以组织病理学作为参考标准。

诊断标准与关键数值

  • 以组织病理学为参考标准,静脉钆特酸增强MR乳腺摄影对浸润性导管癌的诊断符合率为93.5%。
  • 1537例中232例(15.1%)接受了组织病理学检查,浸润性导管癌为最常见诊断(109例,47.0%)。

临床应用与阅片要点

  • 99.2%的患者在钆特酸增强MR乳腺摄影后确立了诊断。
  • 91.6%的患者图像质量评为优秀或良好。
  • 药物不良反应发生于5/1537例(0.3%),其中1例分类为严重(心动过速、吞咽困难、荨麻疹、皮疹),所有出现不良反应的患者检查后均完全恢复。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To perform a large-scale multicenter post-marketing surveillance study for analyzing diagnostic effectiveness and safety of intravenous (IV) gadoteric acid (Dotarem®) in magnetic resonance (MR) mammography under daily practice conditions.

MATERIALS AND METHODS: Patients underwent high-resolution MR mammography with gadoteric acid in 15 German centers. Radiologists used a standardized questionnaire to report data including patient demographics and medical history, characteristics of MR examination and results in terms of diagnosis and safety for the patient.

RESULTS: A total of 1537 patients were examined. In 99.2% of all patients, a diagnosis was established. In 91.6% of all patients, image quality was excellent or good. Histopathological examinations were performed for 232 of 1537 patients (15.1%) with invasive ductal carcinoma being the most frequent diagnosis (109 patients, 47.0%). Based on histopathology as the standard of reference, IV gadoteric acid-enhanced MR mammography confirmed diagnoses of invasive ductal carcinoma in 93.5% of the patients. Adverse drug reactions occurred in 5 of 1537 patients (0.3%) and were classified as serious in one case (tachycardia, dysphagia, urticaria, rash). All patients with adverse drug reactions fully recovered after the examination.

CONCLUSION: This noninterventional surveillance study shows IV gadoteric acid to be a safe and effective contrast agent for use in MR mammography.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Seithe T, Braun J, Wolf M, et al. Diagnostic efficacy and safety of gadoteric acid MR mammography in 1537 patients. Eur J Radiol. 2016. PMID: 27842678. doi:10.1016/j.ejrad.2016.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。